Investigation of a platelet factor 4 polymorphism on the immune response in patients with heparin-induced thrombocytopenia

Platelets

Volumn 11, Issue 1, 2000, Pages 23-27

  Horsewood, Peter ^a,b   Kelton, John G ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; HEPARIN; THROMBOCYTE FACTOR 4;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0034081558     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100075751     Document Type: Article

References (30)

1. 1. Warkentin T E, Kelton J G. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-7.
2. 2. Visentin G P, Aster R H. Heparin-induced thrombocytopenia and thrombosis. Curr Opin Hematol 1995; 2: 351-7.
3. 3. Amiral J, Bridey F, Dreyfus M, Vissac A M, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia. Thromb Haemost 1992; 68: 95-6.
4. 4. Kelton J G, Smith J W, Warkentin T E, Hayward C P M, Denomme G A, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83: 3232-9.
5. 5. Visentin G P, Ford S E, Scott J P, Aster R H. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-8.
6. 6. Greinacher A, Potzch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemostas 1994; 71: 247-51.
7. 7. Warkentin T E, Hayward C P M, Boshkov L K, Santos A V, Sheppard J I, Bode A P, Kelton J G. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin induced thrombocytopenia. Blood 1994; 84: 3691-9.
8. 8. Cines D B, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. New Engl J Med 1987; 316: 581-9.
9. 9. Visentin G P, Malik M, Cyganiak K A, Aster R H. Patients with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes. J Lab Clin Meet 1996; 128: 376-83.
10. 10. Warkentin T E, Levine M N, Hirsh J, Klama N M, Kelton J G. Formation of heparin-induced thrombocytopenia IgG (HIT-IgG) without thrombocytopenia: analysis of a clinical trial [abstract]. Blood 1995; 86: 537.
11. 11. Kappers-Klunne M C, Boon D M S, Hop W C J, Michiels J J, Stibbe J, van der Zwaan C, Koudstaal P J, van Vliet HHDM. Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular disease. Br J Haematol 1997; 96: 442-6.
12. 12. Warmerdam P A M, van der Winkel J G J, Vlug A, Westerdaal N A C, Capel P J A. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991; 147: 1338-43.
13. 13. Brandt J, Isenhart C E, Osborne J M, Ahmed A, Anderson C L. On the role of platelet FcγRIIa phenotype in heparin-induced thrombocytopenia. Thromb Haemost 1995; 74: 1564-72.
14. 14. Burgess J K, Lindeman R, Chesterman C N, Chong B H. Single amino acid mutation of Fcγ receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 1995; 91: 761-6.
15. 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin induced thrombocytopenia and thrombosis. Blood 1997; 89: 370-5.
16. 16. Denomme G A, Warkentin T E, Horsewood P, Sheppard J I, Warner M N, Kelton J G. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the FcγRIIa 'low responder' (his131) gene in patients with heparin-induced thrombocytopenia. J Lab Clin Med 1997; 130: 278-84.
17. 17. Bachelot-Loza C, Saffroy R, Lasne D, Chatellier G, Alach M, Rendu F. Importance of the FcγRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost 1998; 79: 523-8.
18. 18. Carlsson L E, Santoso S, Baurichter G, Kroll H, Papenberg S, Eichler P, Westerdaal N A C, Kiefel V, van der Winkel J G J, Greinacher A. Heparin-induced thrombocytopenia: new insights into the impact of the FcγRIIa-R-H131 polymorphism. Blood 1998; 92: 1526-31.
19. 19. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: The antibody is not heparin specific. Thromb Haemost 1992; 67: 545-9.
20. 20. Anderson G P. Insights into heparin-thrombocytopenia. Br J Haematol 1992; 80: 504-8.
21. 21. Sheridan D, Carter C, Kelton J G. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.
22. 22. Green C J, St Charles R, Edwards B F P, Johnson P H. Identification and characterization of PF4varl, a human gene variant of platelet factor 4.
23. alt. Blood 1990; 76: 336-44.
24. 24. Kelton J G, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy W G. Heparin induced thrombocytopenia: laboratory studies. Blood 1988; 72: 925-30.
25. 25. Chong B H, Fawaz I, Chesterman C N, Berndt M C. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989; 73: 235-40.
26. 26. Greinacher A, Mueller-Eckhardt G. Heparin-associated thrombocytopenia: no association of the immune response with HLA. Vox Sang 1993; 65: 151-3.
27. 27. Horsewood P, Warkentin T E, Hayward C P M, Kelton J G. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 1996; 95: 161-7.
28. 28. Suh J S, Aster R H, Gian P, Visentin M D. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis (HITT) recognize multiple epitopes on heparin:PF4 complexes. Blood 1998; 91: 916-22.
29. 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-81.
30. 30. Valentin N, Visentin G P, Newman P J. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expresion of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood 1995; 85: 3028-33.